// COMPANY
AdvanCell
SECTOR BIOTECHMENTIONS 2LAST SEEN JULY 15, 2026
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·Lucinda Shen·JULY 15, 2026
“AdvanCell, "an Australia-based radiopharmaceutical company focused on cancer, raised $315m in Series D funding."”
02
mention·Lucinda Shen·JULY 15, 2026
“The pattern: healthcare AI and diagnostics are attracting mega-rounds at steep step-ups.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.